Get the Stockscreener App
1.95
6.25%
-0.13
After Hours:
1.97
0.02
+1.03%
Biomea Fusion Inc stock is traded at $1.95, with a volume of 1.43M.
It is down -6.25% in the last 24 hours and up +13.37% over the past month.
Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases. The company uses its proprietary FUSION System discovery platform to develop a pipeline of novel small-molecule product candidates. Its principal clinical program's drug candidate, icovamenib, is being developed as an orally bioavailable, selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity. The company is also developing BMF-650, an investigational, oral small-molecule GLP-1 RA, which has the potential to be a therapeutic option for diabetes and obesity.
See More
Previous Close:
$2.08
Open:
$2.1
24h Volume:
1.43M
Relative Volume:
1.26
Market Cap:
$116.04M
Revenue:
-
Net Income/Loss:
$-144.01M
P/E Ratio:
-0.4863
EPS:
-4.01
Net Cash Flow:
$-113.02M
1W Performance:
+1.04%
1M Performance:
+13.37%
6M Performance:
-28.57%
1Y Performance:
-77.61%
1-Day Range:
$1.95
$2.10
1-Week Range:
$1.86
$2.1065
52-Week Range:
$1.2905
$13.07
Biomea Fusion Inc Stock (BMEA) Company Profile
Name
Biomea Fusion Inc
Sector
Industry
Phone
(650) 980-9099
Address
1599 INDUSTRIAL ROAD, SAN CARLOS
Compare BMEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.95 | 123.78M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-25 | Initiated | Jefferies | Buy |
| Jun-03-25 | Resumed | Piper Sandler | Overweight |
| Oct-09-24 | Initiated | Edward Jones | Buy |
| Sep-27-24 | Upgrade | Rodman & Renshaw | Neutral → Buy |
| Sep-27-24 | Upgrade | Truist | Hold → Buy |
| Aug-29-24 | Initiated | CapitalOne | Overweight |
| Jun-11-24 | Downgrade | Truist | Buy → Hold |
| Jun-07-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-06-24 | Initiated | Truist | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Jun-26-23 | Downgrade | Jefferies | Buy → Hold |
| May-12-23 | Initiated | Barclays | Overweight |
| Mar-29-23 | Reiterated | Oppenheimer | Outperform |
| Mar-28-23 | Reiterated | H.C. Wainwright | Buy |
| Feb-24-23 | Initiated | Citigroup | Buy |
| Jun-02-22 | Resumed | H.C. Wainwright | Buy |
| Jan-12-22 | Initiated | H.C. Wainwright | Buy |
| Dec-17-21 | Initiated | Oppenheimer | Outperform |
| May-11-21 | Initiated | JP Morgan | Overweight |
| May-11-21 | Initiated | Jefferies | Buy |
| May-11-21 | Initiated | Piper Sandler | Overweight |
View All
Biomea Fusion Inc Stock (BMEA) Latest News
Aug Drivers: Is Biomea Fusion Inc. stock a good pick for beginners2025 Growth vs Value & Advanced Swing Trade Entry Plans - khodrobank.com
Rally Mode: Will BioNexus Gene Lab Corp. stock recover after earningsJuly 2025 Recap & Safe Capital Growth Tips - khodrobank.com
Will Biomea Fusion Inc. outperform during market ralliesEarnings Recap Summary & Verified Technical Signals - khodrobank.com
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Fund Flows: Is NNAGW still a buy after recent gainsMarket Growth Review & Stock Timing and Entry Methods - خودرو بانک
Sentiment Watch: Will Biomea Fusion Inc. outperform small cap indexesJuly 2025 EndofMonth & High Win Rate Trade Alerts - khodrobank.com
Aug Update: Will Biomea Fusion Inc. stock hit new highs in YEARFed Meeting & Safe Entry Trade Signal Reports - khodrobank.com
Is EXPO stock good for income investorsWeekly Trade Analysis & Community Trade Idea Sharing Platform - خودرو بانک
Biomea Fusion (BMEA) Unveils Promising Diabetes Therapy Data - GuruFocus
Rate Cut: How volatile is PSAPRN stockWeekly Profit Summary & Expert-Curated Trade Recommendations - خودرو بانک
Biomea Fusion Announces Promising Preclinical Data for Icovamenib Combined with Semaglutide in Type 2 Diabetes Model - Quiver Quantitative
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update - GlobeNewswire
60% Blood Glucose Drop: Biomea's Diabetes Drug Combo Outperforms Semaglutide with Muscle-Sparing Weight Loss - Stock Titan
Earnings Report: Can Biomea Fusion Inc ride the EV waveJuly 2025 Big Picture & Advanced Technical Analysis Signals - خودرو بانک
This Biomea Fusion Insider Increased Their Holding By 200% Last Year - Yahoo Finance
Walleye Capital LLC Sells 148,591 Shares of Biomea Fusion, Inc. $BMEA - MarketBeat
Nuveen LLC Invests $575,000 in Biomea Fusion, Inc. $BMEA - MarketBeat
Is Biomea Fusion Inc. a defensive stockJuly 2025 Highlights & Consistent Profit Focused Trading Strategies - beatles.ru
Is This the Dip to Buy in Biomea Fusion Inc.July 2025 Spike Watch & Long-Term Capital Growth Strategies - beatles.ru
Should value investors consider Biomea Fusion Inc.July 2025 Update & Daily Profit Maximizing Trade Tips - beatles.ru
Is Biomea Fusion Inc. trading at a discountJuly 2025 News Drivers & Fast Gain Swing Trade Alerts - 뉴스영
Is Biomea Fusion Inc. showing signs of accumulation2025 Dividend Review & Weekly Top Gainers Alerts - Newser
Why is Biomea Fusion Inc. stock going upIPO Watch & Momentum Based Trading Signals - خودرو بانک
Is Biomea Fusion Inc. building a consolidation baseRate Hike & Safe Capital Growth Trade Ideas - Newser
What does recent volatility data suggest for Biomea Fusion Inc.Trade Performance Summary & Smart Swing Trading Techniques - Newser
How to monitor Biomea Fusion Inc. with trend dashboards2025 Technical Overview & Real-Time Stock Movement Alerts - Newser
What data driven models say about Biomea Fusion Inc.’s futureJuly 2025 Intraday Action & Community Consensus Stock Picks - Newser
Volatility clustering patterns for Biomea Fusion Inc.2025 AllTime Highs & High Accuracy Swing Trade Signals - Newser
Is Biomea Fusion Inc. in a bullish channelGap Up & Long Hold Capital Preservation Plans - خودرو بانک
Should you hold or exit Biomea Fusion Inc. now2025 Market Sentiment & Smart Investment Allocation Tips - Newser
How to read the order book for Biomea Fusion Inc.2025 AllTime Highs & Weekly Top Gainers Trade List - Newser
Combining machine learning predictions for Biomea Fusion Inc.July 2025 Earnings & Verified High Yield Trade Plans - Newser
How to forecast Biomea Fusion Inc. trends using time seriesMarket Trend Review & Community Shared Stock Ideas - Newser
Is Biomea Fusion Inc. stock ready for a breakoutJuly 2025 Snapshot & Reliable Intraday Trade Alerts - Newser
Why Biomea Fusion Inc. stock attracts strong analyst attention2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Is Biomea Fusion Inc. stock trending bullishDay Trade & Real-Time Volume Triggers - خودرو بانک
Forecasting Biomea Fusion Inc. price range with options dataJuly 2025 Intraday Action & Community Trade Idea Sharing - Newser
Is Biomea Fusion Inc. showing insider buyingJuly 2025 Rallies & Precise Buy Zone Identification - خودرو بانک
Signal strength of Biomea Fusion Inc. stock in tech scannersWeekly Gains Report & Verified Swing Trading Watchlist - Newser
Advanced analytics toolkit walkthrough for Biomea Fusion Inc.Quarterly Trade Review & High Conviction Buy Zone Alerts - Newser
What’s next for Biomea Fusion Inc. stock priceJuly 2025 Review & Target Return Focused Picks - Newser
What to do if you’re stuck in Biomea Fusion Inc.Long Setup & Weekly Setup with ROI Potential - Newser
Will Biomea Fusion Inc. benefit from macro trendsJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Biomea Fusion (NASDAQ:BMEA) Now Covered by Jefferies Financial Group - MarketBeat
Sector ETF performance correlation with Biomea Fusion Inc.July 2025 Levels & Technical Entry and Exit Tips - Newser
Can Biomea Fusion Inc. benefit from deglobalizationMarket Risk Report & Technical Confirmation Alerts - خودرو بانک
Will Biomea Fusion Inc. stock hit new highs in YEAREarnings Growth Report & Technical Confirmation Alerts - خودرو بانک
Surprises Report: Is Biomea Fusion Inc. part of any ETFJuly 2025 Technicals & Reliable Price Breakout Alerts - خودرو بانک
Will Biomea Fusion Inc. stock recover after recent dropEntry Point & Safe Entry Momentum Tips - Newser
Will Biomea Fusion Inc. benefit from sector rotationCPI Data & Fast Moving Stock Trade Plans - khodrobank.com
What MACD and RSI say about Biomea Fusion Inc.2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
Biomea Fusion Inc Stock (BMEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):